Should we be using cimetidine to premedicate patients receiving docetaxel or paclitaxel?

Gynecol Oncol. 2004 Oct;95(1):270-1. doi: 10.1016/j.ygyno.2004.07.029.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Carboplatin / administration & dosage
  • Carboplatin / pharmacokinetics
  • Cimetidine / administration & dosage
  • Cimetidine / pharmacology*
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacokinetics
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / metabolism
  • Docetaxel
  • Drug Synergism
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / enzymology
  • Paclitaxel / administration & dosage
  • Paclitaxel / pharmacokinetics
  • Taxoids / administration & dosage
  • Taxoids / pharmacokinetics

Substances

  • Taxoids
  • Docetaxel
  • Cimetidine
  • Cytochrome P-450 Enzyme System
  • Carboplatin
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A
  • Paclitaxel
  • Cisplatin